Synopsys (SNPS) Projected to Post Earnings on Wednesday

Synopsys (NASDAQ:SNPS) is expected to be releasing its Q3 2025 earnings data before the market opens on Wednesday, August 20th. Analysts expect Synopsys to post earnings of $3.84 per share and revenue of $1.77 billion for the quarter. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS and its Q3 2025 guidance at 3.820-3.87 EPS.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.60 billion. During the same period last year, the company posted $3.00 earnings per share. The firm’s revenue was up 10.3% compared to the same quarter last year. On average, analysts expect Synopsys to post $11 EPS for the current fiscal year and $13 EPS for the next fiscal year.

Synopsys Trading Up 1.6%

NASDAQ:SNPS opened at $625.80 on Wednesday. The business’s 50-day moving average is $550.67 and its two-hundred day moving average is $495.74. The company has a debt-to-equity ratio of 1.01, a current ratio of 7.02 and a quick ratio of 6.85. Synopsys has a 12 month low of $365.74 and a 12 month high of $651.73. The firm has a market capitalization of $97.10 billion, a PE ratio of 45.18, a price-to-earnings-growth ratio of 4.08 and a beta of 1.15.

Analysts Set New Price Targets

SNPS has been the topic of several research reports. Piper Sandler raised their price objective on Synopsys from $615.00 to $660.00 and gave the company an “overweight” rating in a research report on Monday, July 21st. Mizuho cut their price objective on Synopsys from $650.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 15th. Morgan Stanley reissued an “overweight” rating and issued a $715.00 price objective (up from $540.00) on shares of Synopsys in a research report on Monday. Needham & Company LLC reaffirmed a “buy” rating and set a $660.00 target price (up from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. Finally, The Goldman Sachs Group initiated coverage on Synopsys in a research report on Thursday, July 10th. They set a “buy” rating and a $620.00 target price on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $630.67.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 7,310 shares of the business’s stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the completion of the sale, the chief financial officer directly owned 15,291 shares of the company’s stock, valued at $7,427,144.52. The trade was a 32.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CRO Richard S. Mahoney sold 9,010 shares of Synopsys stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the completion of the transaction, the executive owned 1,485 shares of the company’s stock, valued at approximately $699,746.85. The trade was a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,686 shares of company stock valued at $13,001,048 over the last three months. 0.62% of the stock is owned by insiders.

Hedge Funds Weigh In On Synopsys

Hedge funds and other institutional investors have recently bought and sold shares of the stock. NewEdge Advisors LLC boosted its position in shares of Synopsys by 15.1% during the first quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after buying an additional 395 shares during the period. Integrated Wealth Concepts LLC boosted its position in shares of Synopsys by 11.6% during the first quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after buying an additional 79 shares during the period. Finally, Brighton Jones LLC boosted its position in shares of Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after buying an additional 50 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.